{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:42:12Z","timestamp":1791315732687,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.jconrel.2003.09.016","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T11:44:37Z","timestamp":1071315877000},"page":"155-161","source":"Crossref","is-referenced-by-count":45,"title":["Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells"],"prefix":"10.1016","volume":"94","author":[{"given":"Bo B.","family":"Lundberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2003.09.016_BIB1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/08982109809035537","article-title":"Controlling the drug delivery attributes of lipid-based drug formulations","volume":"8","author":"Bally","year":"1998","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(94)90122-8","article-title":"The solubilization of lipophilic derivatives of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture","volume":"109","author":"Lundberg","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.2042-7158.1997.tb06744.x","article-title":"A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (taxol)","volume":"49","author":"Lundberg","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB4","first-page":"453","article-title":"Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions","volume":"13","author":"Lundberg","year":"1998","journal-title":"Anti-Cancer Drug Des."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB5","first-page":"6371","article-title":"Effect of lipid composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies","volume":"50","author":"Gabizon","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00003495-199700544-00004","article-title":"Liposomes. Opportunities in drug delivery","volume":"54","author":"Allen","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/08982109809039930","article-title":"Targeting of drugs to solid tumors using anti-HER2 immunoliposomes","volume":"8","author":"Papahadjopoulos","year":"1998","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB8","first-page":"3320","article-title":"In vivo and in vitro targeting of immunoliposomal doxorubicin to human B-cell lymphoma","volume":"58","author":"Lopes de Menezes","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0005-2736(00)00334-5","article-title":"Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer","volume":"1510","author":"Moase","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0005-2736(01)00386-8","article-title":"A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer","volume":"1514","author":"Moreira","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jnci\/81.8.570","article-title":"Delivery of novel therapeutic agents in tumors: physiological barriers and strategies","volume":"81","author":"Jain","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1211\/0022357991776787","article-title":"Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions","volume":"51","author":"Lundberg","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(00)00492-0","article-title":"Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin","volume":"205","author":"Lundberg","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj3200293","article-title":"Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas","volume":"320","author":"Hansen","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<985::AID-IJC23>3.0.CO;2-W","article-title":"Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies","volume":"81","author":"Griffiths","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB16","first-page":"1505","article-title":"Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with 111Indium, 67Gallium, or 90Yttrium","volume":"7","author":"Ochakovskaya","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jps.2600830117","article-title":"Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures","volume":"83","author":"Lundberg","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-5173(96)04456-0","article-title":"Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time","volume":"134","author":"Lundberg","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB19","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/bi00472a025","article-title":"Endocytosis and intracellular fate of liposomes using pyranine as a probe","volume":"29","author":"Straubinger","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(95)00138-S","article-title":"Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures","volume":"1239","author":"Hansen","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB22","first-page":"7190","article-title":"Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs","volume":"62","author":"Sapra","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1081\/LPR-120004771","article-title":"Adventures in targeting","volume":"12","author":"Allen","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/bi962148u","article-title":"Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro","volume":"36","author":"Kirpotin","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08982109909024786","article-title":"Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells","volume":"9","author":"Lopes de Menezes","year":"1999","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-2736(99)00091-7","article-title":"Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells","volume":"1420","author":"Koning","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1007565230130","article-title":"Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel","volume":"17","author":"Constantinides","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5173(00)00329-X","article-title":"Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds","volume":"200","author":"Perkins","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-3659(01)00343-1","article-title":"The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity","volume":"74","author":"Bom","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2003.09.016_BIB30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00280-002-0437-3","article-title":"Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients","volume":"49","author":"Maranhao","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2003.09.016_BIB31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002620000102","article-title":"Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice","volume":"49","author":"Shih","year":"2000","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590300467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590300467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T05:51:25Z","timestamp":1550296285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836590300467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S016836590300467X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2003.09.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}